Cervical Ripening Balloon, 3 Hours vs 12 Hours Placement
Comparison of Labor Induction With Cervical Ripening Balloon, 3 Hours vs 12 Hours Placement: a Randomized Controlled Trail
1 other identifier
interventional
164
1 country
1
Brief Summary
The goal of this clinical trial is to learn if a shorter duration of cervical ripening balloon (CRB) placement can reduce the time to delivery in pregnant women undergoing induction of labor. The main questions it aims to answer are: Does placing the cervical ripening balloon for 3 hours or less result in a shorter interval from insertion to delivery compared to the standard 12-hour placement? Does a shorter 3-hour balloon placement lead to better pregnancy outcomes, fewer complications, and lower maternal discomfort? Researchers will compare a group of participants who have the balloon removed after 3 hours to a control group who have the balloon removed after 12 hours to see if the shorter duration decreases the overall time to delivery. Participants will: Sign an informed consent and be randomized into one of the two groups (3 hours vs. 12 hours). Undergo the standard procedure of a double-lumen Cook cervical ripening balloon insertion. Have the balloon removed after approximately 3 hours or 12 hours depending on their assigned group. Proceed with amniotomy or Pitocin use at the discretion of the labor and delivery physician. Complete a Birth Satisfaction Scale questionnaire and have their maternal and neonatal health outcomes tracked from the hospital's database.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2026
CompletedFirst Submitted
Initial submission to the registry
June 30, 2026
CompletedFirst Posted
Study publicly available on registry
July 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2028
July 8, 2026
July 1, 2026
2 years
June 30, 2026
July 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Insertion-to-Delivery Time Interval
The time interval (in hours) from the successful insertion of the cervical ripening balloon to the time of fetal delivery (whether vaginal or cesarean section).
From the time of balloon insertion up to delivery (approximately 48 hours).
Secondary Outcomes (5)
Mode of Delivery
At the time of delivery.
Time to Active Phase and Second Stage of Labor
From balloon insertion up to delivery, assessed up to 48 hours after balloon insertion.
Maternal Complications
From balloon insertion up to 48 hours postpartum.
Adverse Neonatal Outcomes
From birth up to newborn discharge or 7 days of life.
Duration of Hospitalization
From admission for induction up to hospital discharge (approximately 3-5 days).
Study Arms (2)
3 hours balloon group
EXPERIMENTALDouble-balloon cervical ripening catheter inserted and left in place for 3 hours before removal
12 hours balloon group
ACTIVE COMPARATORDouble-balloon cervical ripening catheter inserted and left in place for 12 hours before removal
Interventions
Use of a transcervical balloon catheter for pre-induction cervical ripening. The catheter is inserted through the cervix, the balloon(s) inflated with sterile saline. The device remains in place for 3 hours.
Use of a transcervical balloon catheter for pre-induction cervical ripening. The catheter is inserted through the cervix, the balloon(s) inflated with sterile saline. The device remains in place for 12 hours.
Eligibility Criteria
You may qualify if:
- Nulliparous or multiparous pregnant women.
- Gestational age between 37 0/7 and 41 6/7 weeks of gestation.
- Maternal age between 18 and 45 years.
- Participant has provided signed informed consent.
You may not qualify if:
- Presence of any contraindications for vaginal delivery.
- Multifetal gestation.
- Rupture of membranes prior to balloon insertion.
- Favorable cervix, defined as a Bishop score greater than 6.
- Cervical dilation greater than 2 cm.
- Previous cesarean delivery or any other prior major uterine surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rambam Health Care Campus
Haifa, 31906, Israel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
June 30, 2026
First Posted
July 8, 2026
Study Start
May 27, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
November 1, 2028
Last Updated
July 8, 2026
Record last verified: 2026-07